News

Deal Announcements

Arcion Therapeutics Secures Venture Capital Debt

Wednesday, October 3, 2012 5:57:00 AM PDT | VentureDeal
   Baltimore, Maryland  --  Biotechnology company Arcion Therapeutics has received $1.5 million in venture capital debt financing, according to an SEC regulatory filing.

Arcion is developing new targeted treatments for moderate and severe pain.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1